bannerHON
img
HONnews
HONnews
img PATIENT / PARTICULIER img PROFESSIONNEL DE SANTE img WEBMESTRE img
img
 
img
HONcode sites
Khresmoi - new !
HONselect
News
Conferences
Images

Themes:
A B C D E F G H I
J K L M N O P Q
R S T U V W X Y Z
Browse archive:
2018: N O S A J J M A M F J
2017: D N

 
  Other news for:
Brain Neoplasms
Neoplasms
Kidney Calculi
 Resources from HONselect
Childhood Cancer Impacts Mental Health

By Robert Preidt

WEDNESDAY, June 13, 2018 (HealthDay News) -- Children with neuroblastoma, a pediatric cancer of nerve cells, are vulnerable to mental health and behavioral problems, a new study finds.

Neuroblastoma is diagnosed at a median age of 17.3 months. Treatment advances have prolonged survival for many patients, the study authors said.

This study included 859 children younger than 18 who had been diagnosed with neuroblastoma at least five years earlier. Their median age at diagnosis was 0.8 years and they were followed for a median of 13.3 years.

The neuroblastoma survivors were compared with 872 siblings of childhood cancer survivors.

The neuroblastoma patients were more likely than the siblings to have anxiety/depression (19 percent vs. 14 percent), headstrong behavior (19 percent vs. 13 percent), attention deficits (21 percent vs. 13 percent), peer conflict/social withdrawal (26 percent vs. 17 percent), and antisocial behavior (16 percent vs. 12 percent).

"These findings are novel because this is the first large study that could look at how neuroblastoma patients are doing in terms of psychological and educational outcomes. Before recent advances in treatment, this survivor population was much smaller and we were not able to analyze these sorts of long-term outcomes," said study author Dr. Nina Kadan-Lottick, from Yale University School of Medicine.

The common treatments for neuroblastoma -- vincristine, cisplatin and retinoic acid -- were not associated with these problems. But survivors who developed chronic health conditions as a result of their cancer treatment were at increased risk for the mental health/behavioral issues, the researchers said.

Specifically, pulmonary disease was linked with an increased risk of all five problems, and endocrine disease and peripheral neuropathy were each linked with increased risk of three of the problems.

The researchers also found that neuroblastoma survivors who developed mental health/behavioral problems tended to require special education services and to not go on to college.

The study results were published online June 11 in the journal Cancer.

"Our hope is that these findings will help inform strategies for early screening and intervention to identify those survivors at highest risk for developing psychological and educational impairment later on in life," Kadan-Lottick said in a journal news release.

More information

The U.S. National Cancer Institute has more on neuroblastoma.

SOURCE: Cancer, news release, June 11, 2018

Copyright © 2018 HealthDay. All rights reserved. URL:http://consumer.healthday.com/Article.asp?AID=734713

Resources from HONselect: HONselect is the HON's medical search engine. It retrieves scientific articles, images, conferences and web sites on the selected subject.
Neoplasms
Mental Health
Neuroblastoma
Survivors
Therapeutics
Risk
Research Personnel
Behavior
The list of medical terms above are retrieved automatically from the article.

Disclaimer: The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare professional.
Be advised that HealthDay articles are derived from various sources and may not reflect your own country regulations. The Health On the Net Foundation does not endorse opinions, products, or services that may appear in HealthDay articles.


Home img About us img MediaCorner img HON newsletter img Site map img Ethical policies img Contact